Skip to content
drillr.ai
Sign up

000952.SZ

广济药业

SZSE · Healthcare · C 制造业 · CN

CNY 6.32
−0.94%
Ask drillr

  • Aug 27, 2026, 08:07 UTC

    Guangji Pharmaceutical announced its first-half 2026 results, reporting a net loss attributable to shareholders of 57.9451 million yuan, compared with a loss of 75.5151 million yuan in the same period of 2025.

    Source:

  • Aug 27, 2026, 03:54 UTC

    Guangji Pharmaceutical announced that its application for a 2026 private placement of shares was accepted by the Shenzhen Stock Exchange on August 26, 2026.

    Source: